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Observations on Aureomycin 
Therapy 
C. H. Chivers, D.V.M.* 
A wide variety of infections is found 
in the clinical material submitted to the 
Veterinary Clinic at Iowa State College. 
Some of these infections are relatively 
easy to control by pharmaceutic, biologic 
or antibiotic agents, by surgical proced-
ures or by combinations of these meth-
ods. Other types of infection have proved 
themselves to be stubbornly resistant to 
such agents and methods as have here-
to-fore been available to the clinician. 
An organism belonging near the head 
of this list is Corynebacterium pyogenes. 
Short of surgical amputation of infected 
parts little benefit could be obtained by 
methods of treatment known up to the 
present time. This organism localized in 
nearly any organ, structure or part of 
the body, especially in bovines, having 
been found from the feet to the brain of 
cattle autopsied at the Veterinary Clinic 
post mortem laboratory. 
Recently a supply of newly developed 
antibiotic known as *aureomycin was 
made available to the Veterinary Clinic 
for experimental use on animals. The 
purpose of this was to gain information as 
to what types of infections might be con-
trolled by its use, on what species of 
animals it could be used, methods of ad-
ministration, side or after effects, some 
ideas of dosage and length of treatment. 
Needless to say the use of aureomycin 
was directed toward those types of cases 
which were not amenable to known 
* Editors note: Dr. Chivers is on the staff of 
the Iowa State College Veterinary Clinic. A 
subsequent article on Aureomycin therapy will 
follow in Volume XIII. 
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treatments an,d to those which would 
otherwise involve rather drastic surgical 
procedures with unfavorable prognosis. 
Results Obtained 
Some interesting results have been ob-
tained in the limited group of cases in 
which aureomycin has been used to 
date. These cases are too few in number 
to justify drawing many definite con-
clusions but there is reason to hope that 
the veterinary clinician has a valuable 
addition to his therapeutic weapons. A 
certain amount of information has been 
gained concerning dosage, methods of 
administration, species of animals treat-
ed, length of treatment and side or after 
effects. The suggested dosage was one 
gram per 200 lbs. body weight per day, 
continued for four days, then reduced 
50 percent for the rest of the treatment. 
Aureomycin is cumulative in tissue cells 
and the reduced dosage will maintain an 
adequate therapeutic action even after it 
disappears from the blood. This is in 
contrast to the sulfonamides where a 
certain blood stream level or concentra-
tion must be maintained. This dosage 
seems to be adequate although in some 
cases it was increased by as much as 
500 per cent with good results and no 
toxic effect. Treatment should be con-
tinued to effect, depending on results. In 
herbivorous animals aureomycin cannot 
be given per orum because it inhibits or 
destroys the bacterial flora of the intest-
inal tract, causing an immediate loss of 
appetite and intestinal functions in gen-
eral. It is irritating to tissues when in-
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J 'cted subcutaneously or intramuscularly, 
least in bovines and equines but 
apparently less so in canines. Small 
quantities accidentally injected intrader-
mally or subcutaneously produced swell-
ing and induration lasting five to seven 
days but apparently no necrosis or 
sloughing. In equines and bovines a 2 per 
cent solution given by the intravenous or 
intraperitoneal routes causes no visible 
reaction, either local or general and can 
be given rather rapidly. 
Some Case Reports 
The cases treated include two horses 
with alveolar periostitis and sinusitis 
and one horse with sinusitis due to trau-
matic injury. After a course of aureo-
mycin therapy all pus formation ceased 
and the odor of necrotic bone dis-
appeared. The infections involved were 
not identified. Four cattle with necrotic 
laryngitis due to Corynebacterium pyo-
genes were treated with aureomycin and 
all made complete recoveries. These were 
cases with an extremely unfavorable 
prognosis under any previous type of 
treatment. Two cattle with Corynebac-
teruim pyogenes abscesses about the head 
and throat were treated with aureomycin 
and healed satisfactorily with a minimum 
of surgical drainage and scarring. One 
cow in a moribund condition from an ad-
vanced case of Corynebacterium pyogenes 
mastitis was placed on aureomycin ther-
apy. The mastitis was not cured but the 
cow lived and gained weight. A cow with 
clinical symptoms similar to those seen 
in Listerellosis made an immediate re-
sponse and complete recovery on a short 
course of aureomycin. A five week old 
calf suffering with the pneumonia-enter-
itis syndrome commonly called calf scours 
and in a moribund condition was given 
a four day course of aureomycin. In 24 
hours a startling improvement was noted 
and in four days it was discharged as 
cured. Another calf, two days old, very 
sick with calf scours, from a herd where 
all newborn calves had died early was 
brought in. It was given 200 cc. of cow's 
blood and one large dose of aureomycin. 
In 18 hours it appeared normal. It was 
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kept under observation for a week with 
no signs of a relapse seen. These two 
calves made the most remarkable recov-
eries of any in this series. 
When consideration is given to the fact 
that all of the cattle in this study could 
have been expected to die it would seem 
that veterinarians have reason to hope 
that aureomycin will be a very valuable 
drug. It will be interesting to continue 
this study. 
* Courtesy Lederle Laboratories. 
Marshall Plan Study 
A Marshall Plan study of animal genet-
ics took two Irish livestock breeding 
technicians to five U. S. colleges and 
the Chicago stockyards early this year, 
the Economic Cooperation Administration 
reported. 
The study is being made by John 
Beatty and Edward O'Mahony of Ire-
land's Department of Agriculture, under 
an ECA technical assistance project. They 
arrived in the United States Jan. 13. 
Beatty returned to Ireland Feb. 18, but 
O'Mahony will remain here for six 
months. 
O'Mahony's study was announced pre-
viously by ECA as one of five livestock 
research projects for technicians from 
Ireland's Department of Agriculture. 
Subsequently, the Irish Government re-
quested that Beatty accompany O'Mahony 
for one month to obtain information on 
American livestock programs to improve 
milk and meat production. 
According to a recent bulletin from 
the Gaines Dog Research Center the 
total dog population of the U.S. is ap-
proximately 22,000,000; the average dog 
in the United States today is 3.9 years of 
age; one dog owner out of four has more 
than one dog; for the country as a whole 
there are 1.4 dogs per dog-owning 
family. 
Scottish terriers seem to be predispos-
. ed to leukemia. 
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